Lampropoulos Justin J. 4
4 · MERIT MEDICAL SYSTEMS INC · Filed Jun 20, 2019
Insider Transaction Report
Form 4
Lampropoulos Justin J.
EXEC. V.P. MKTG & STRATEGY
Transactions
- Exercise/Conversion
Common Stock
2019-06-19$13.14/sh+8,000$105,120→ 8,000 total - Sale
Common Stock
2019-06-19$60.87/sh−8,000$486,928→ 0 total - Exercise/Conversion
Non-qualified stock options (right to buy)
2019-06-19−8,000→ 0 totalExercise: $13.14From: 2014-07-31Exp: 2020-07-31→ Common Stock (8,000 underlying)
Holdings
- 20,000
Non-qualified stock options (right to buy)
Exercise: $17.27From: 2016-02-13Exp: 2022-02-13→ Common Stock (20,000 underlying) - 20,000
Non-qualified stock options (right to buy)
Exercise: $16.05From: 2017-01-28Exp: 2023-01-28→ Common Stock (20,000 underlying) - 20,000
Non-qualified stock options (right to buy)
Exercise: $44.80From: 2019-03-02Exp: 2025-03-02→ Common Stock (20,000 underlying) - 30,000
Non-qualified stock options (right to buy)
Exercise: $55.73From: 2020-03-01Exp: 2026-03-01→ Common Stock (30,000 underlying) - 25,000
Non-qualified stock options (right to buy)
Exercise: $28.20From: 2018-04-14Exp: 2024-04-14→ Common Stock (25,000 underlying) - 5,000
Non-qualified stock options (right to buy)
Exercise: $12.06From: 2015-10-04Exp: 2021-10-04→ Common Stock (5,000 underlying)
Footnotes (8)
- [F1]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.70 to $60.98, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F2]Becomes exercisable in equal annual installments of 20% commencing on 07/31/2014.
- [F3]Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015.
- [F4]Becomes exercisable in equal annual installments of 20% commencing on 02/13/2016.
- [F5]Becomes exercisable in equal annual installments of 20% commencing on 01/28/2017.
- [F6]Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018.
- [F7]Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.
- [F8]Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020.